PCOS-Related Weight ManagementPCOS-Related Weight Management
Prevalência: 6-12% of reproductive-age women; 60-80% of PCOS patients are overweight/obese
Evidence-Ranked Ingredients
About
Polycystic ovary syndrome affects 6-12% of reproductive-age women and is characterized by hyperandrogenism, insulin resistance, and chronic inflammation. Insulin resistance drives hyperinsulinemia, which stimulates ovarian androgen production, creating a vicious cycle that makes weight loss exceptionally difficult.
Common Symptoms
Risk Factors
- Genetic predisposition
- Insulin resistance
- Hyperandrogenism
- Chronic inflammation
- Family history
- Obesity
Frequently Asked Questions
What supplements may help with PCOS-Related Weight Management?
How is the evidence for PCOS-Related Weight Management supplements graded?
How many studies on PCOS-Related Weight Management supplements have been reviewed?
What are common symptoms of PCOS-Related Weight Management?
Related Conditions
Condições que partilham ingredientes estudados
Aviso Legal da FDA: Estas declarações não foram avaliadas pela Food and Drug Administration. Os produtos e informações neste site não se destinam a diagnosticar, tratar, curar ou prevenir qualquer doença. As notas de evidência apresentadas são baseadas em nossa análise de pesquisas revisadas por pares publicadas e não constituem aconselhamento médico. Sempre consulte seu profissional de saúde antes de iniciar qualquer regime de suplementação.